Antibody response to melanoma helper-peptide vaccine correlates with survival

Por Olson, Walter C, Reed, Caroline M, Slingluff, Craig L
Publicado em 2013

T cells in the human metastatic melanoma microenvironment express site-specific homing receptors and retention integrins

Por Salerno, Elise P, Olson, Walter C, McSkimming, Chantel, Shea, Sofia, Slingluff, Craig L
Publicado em 2014

Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival

Por Reed, Caroline M., Cresce, Nicole D., Mauldin, Ileana S., Slingluff, Craig L., Olson, Walter C.
Publicado no Clin Cancer Res (2015)

TLR2/6 agonists and interferon-gamma induce human melanoma cells to produce CXCL10

Por Mauldin, Ileana S., Wang, Ena, Deacon, Donna H., Olson, Walter C., Bao, Yongde, Slingluff, Craig L.
Publicado no Int J Cancer (2015)

Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T Cell Receptor and is modulated by IL-2

Por Molhoek, Kerrington R., McSkimming, Chantel C., Olson, Walter C., Brautigan, David L., Slingluff, Craig L.
Publicado em 2008

Vaccine-draining lymph nodes of cancer patients for generating anti-cancer antibodies

Por Shukla, Girja S., Olson, Walter C., Pero, Stephanie C., Sun, Yu-jing, Carman, Chelsea L., Slingluff, Craig L., Krag, David N.
Publicado no J Transl Med (2017)

Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine

Por Hu, Yinin, Petroni, Gina R., Olson, Walter C., Czarkowski, Andrea, Smolkin, Mark E., Grosh, William W., Chianese-Bullock, Kimberly A., Slingluff, Craig L.
Publicado em 2014

Immunologic hierarchy and promiscuity of melanoma helper peptides

Por Hu, Yinin, Petroni, Gina R, Olson, Walter C, Czarkowski, Andrea, Smolkin, Mark, Grosh, William W, Rehm, Patrice K, Murphy, Cheryl F, Coleman, Elizabeth J
Publicado em 2013

Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield,...

Por Olson, Walter C, Smolkin, Mark E, Farris, Erin M, Fink, Robyn J, Czarkowski, Andrea R, Fink, Jonathan H, Chianese-Bullock, Kimberly A, Slingluff, Craig L
Publicado em 2011

Activation, dysfunction and retention of T cells in vaccine sites after injection of incomplete Freund’s adjuvant, with or without peptide

Por Salerno, Elise P., Shea, Sofia M., Olson, Walter C., Petroni, Gina R., Smolkin, Mark E., McSkimming, Chantel, Chianese-Bullock, Kimberly A., Slingluff, Craig L.
Publicado em 2013

A multi-epitope melanoma helper peptide vaccine durably increases Th1 cytokine production by responding lymphocytes

Por Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L
Publicado em 2013

A melanoma helper peptide vaccine increases Th1 cytokine production by leukocytes in peripheral blood and immunized lymph nodes

Por Dillon, Patrick M, Olson, Walter C, Czarkowski, Andrea, Petroni, Gina R, Smolkin, Mark, Grosh, William W, Chianese-Bullock, Kimberly A, Deacon, Donna H, Slingluff, Craig L
Publicado em 2014

A randomized pilot trial evaluating safety and immunogenicity of recMAGE-A3 + AS15 immunotherapeutic administered by intramuscular versus intradermal/subcutaneous routes

Por Slingluff, Craig L, Petroni, Gina R, Olson, Walter C, Chianese-bullock, Kimberly A, Smith, Kelly T, Smolkin, Mark E, Galeassi, Nadedja, Grosh, William, Weiss, Geoffrey, Scott, Kristy, Hornillo, Ana
Publicado no J Immunother Cancer (2014)

EFFECT OF GM-CSF ON CIRCULATING CD8(+) AND CD4(+) T CELL RESPONSES TO A MULTIPEPTIDE MELANOMA VACCINE: OUTCOME OF A MULTICENTER RANDOMIZED TRIAL

Por Slingluff, Craig L., Petroni, Gina R., Olson, Walter C., Smolkin, Mark E., Ross, Merrick I., Haas, Naomi B., Grosh, William W., Boisvert, Marc E, Kirkwood, John M., Chianese-Bullock, Kimberly A.
Publicado em 2009

Evaluation of SAS1B as a target for antibody-drug conjugate therapy in the treatment of pancreatic cancer

Por Knapp, Kiley A., Pires, Eusebio S., Adair, Sara J., Mandal, Arabinda, Mills, Anne M., Olson, Walter C., Slingluff, Craig L., Parsons, J. Thomas, Bauer, Todd W., Bullock, Timothy N., Herr, John C.
Publicado no Oncotarget (2018)

A pilot study of the immunogenicity of a 9-peptide breast cancer vaccine plus poly-ICLC in early stage breast cancer

Por Dillon, Patrick M., Petroni, Gina R., Smolkin, Mark E., Brenin, David R., Chianese-Bullock, Kimberly A., Smith, Kelly T., Olson, Walter C., Fanous, Ibrahim S., Nail, Carmel J., Brenin, Christiana M., Hall, Emily H., Slingluff, Craig L.
Publicado no J Immunother Cancer (2017)

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine

Por Mauldin, Ileana S, Wages, Nolan A, Stowman, Anne M, Wang, Ena, Smolkin, Mark E, Olson, Walter C, Deacon, Donna H, Smith, Kelly T, Galeassi, Nadejda, Teague, Jessica E, Clark, Rachael A, Marincola, Francesco M, Petroni, Gina R, Mullins, David W, Slingluff, Craig L
Publicado no J Immunother Cancer (2015)

A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites

Por Slingluff, Craig L., Petroni, Gina R., Olson, Walter C., Smolkin, Mark E., Chianese-Bullock, Kimberly A., Mauldin, Ileana S., Smith, Kelly T., Deacon, Donna H., Varhegyi, Nikole E., Donnelly, Sean B., Reed, Caroline M., Scott, Kristy, Galeassi, Nadejda V., Grosh, William W.
Publicado no Cancer Immunol Immunother (2015)

Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases

Por Mauldin, Ileana S., Wages, Nolan A., Stowman, Anne M., Wang, Ena, Smolkin, Mark E., Olson, Walter C., Deacon, Donna H., Smith, Kelly T., Galeassi, Nadedja V., Chianese‐Bullock, Kimberly A., Dengel, Lynn T., Marincola, Francesco M., Petroni, Gina R., Mullins, David W., Slingluff, Craig L.
Publicado no Cancer Immunol Immunother (2016)

Topical treatment of melanoma metastases with imiquimod, plus administration of a cancer vaccine, promotes immune signatures in the metastases

Por Mauldin, Ileana S., Wages, Nolan A., Stowman, Anne M., Wang, Ena, Olson, Walter C., Deacon, Donna H., Smith, Kelly T., Galeassi, Nadedja, Teague, Jessica E., Smolkin, Mark E., Chianese‐Bullock, Kimberly A., Clark, Rachael A., Petroni, Gina R., Marincola, Francesco M., Mullins, David W., Slingluff, Craig L.
Publicado no Cancer Immunol Immunother (2016)